Effect of dietary fiber on circulating C-reactive protein in overweight and obese adults: A meta-analysis of randomized controlled trials

International Journal of Food Sciences and Nutrition

Volumn 66, Issue 1, 2015, Pages 114-119

  Jiao, Jun ^a   Xu, Jia Ying ^a   Zhang, Weiguo ^b   Han, Shufen ^a   Qin, Li Qiang ^a  

^a SOOCHOW UNIVERSITY   (China)

^b DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

Author keywords

C reactive protein; Cardiovascular disease; Dietary fiber; Obesity; Overweight

Indexed keywords

C REACTIVE PROTEIN;

ADMINISTRATION AND DOSAGE; BLOOD; CHEMISTRY; DIETARY FIBER; FACTUAL DATABASE; HUMAN; META ANALYSIS; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY AND SPECIFICITY;

C-REACTIVE PROTEIN; DATABASES, FACTUAL; DIETARY FIBER; HUMANS; OBESITY; OVERWEIGHT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY;

EID: 84922749201     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.3109/09637486.2014.959898     Document Type: Article

References (36)

1. Andersson A, Tengblad S, Karlströ m B, Kamal-Eldin A, Landberg R, Basu S, Aman P, Vessby B. 2007. Whole-grain foods do not affect insulin sensitivity or markers of lipid peroxidation and inflammation in healthy, moderately overweight subjects. J Nutr 137:1401-1407.
2. Andon M. 2012. Petition for a qualified health claim for whole grains and reduced risk of diabetes mellitus type 2 (Docket No. FDA-2012-Q-0242) Available at: http://www.fda.gov/downloads/food/ingredientspackaginglabeling/labelingnutrition/ucm368051.pdf. Accessed on 25 March 2014.
3. Ashraf MJ, Baweja P. 2013. Obesity: the 'huge' problem in cardiovascular diseases. Mo Med 110:499-504.
4. Brownlee IA, Moore C, Chatfield M, Richardson DP, Ashby P, Kuznesof SA, Jebb SA, Seal CJ. 2010. Markers of cardiovascular risk are not changed by increased whole-grain intake: the WHOLEheart study, a randomised, controlled dietary intervention. Br J Nutr 104:125-134.
5. Buyken AE, Goletzke J, Joslowski G, Felbick A, Cheng G, Herder C, Brand-Miller JC. 2014. Association between carbohydrate quality and inflammatory markers: systematic review of observational and interventional studies. Am J Clin Nutr 99:813-833.
6. Choi JL, Joseph L, Pilote L. 2013. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev 14:232-244.
7. Dall'Alba V, Silva FM, Antonio JP, SteemburgoT, Royer CP, Almeida JC, Gross JL, Azevedo MJ. 2013. Improvement of the metabolic syndrome profile by soluble fibre - guar gum - in patients with type 2 diabetes: a randomised clinical trial. Br J Nutr 110:1601-1610.
8. de Heredia FP, Gómez-Martínez S, Marcos A. 2012. Obesity, inflammation and the immune system. Proc Nutr Soc 71:332-338.
9. de Mello VD, Schwab U, Kolehmainen M, Koenig W, Siloaho M, Poutanen K, Mykkänen H, Uusitupa M. 2011. A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: the Sysdimet study. Diabetologia 54:2755-2767.
10. Egger M, Davey Smith G, Schneider M, Minder C. 1997. Bias in metaanalysis detected by a simple, graphical test. Br Med J 315:629-634.
11. Fardet A. 2010. New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre? Nutr Res Rev 23:65-134.
12. Fujii H, Iwase M, Ohkuma T, Ogata-Kaizu S, Ide H, Kikuchi Y, Idewaki Y, et al. 2013. Impact of dietary fiber intake on glycemic control, cardiovascular risk factors and chronic kidney disease in Japanese patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry. Nutr J 12:159.
13. Georg Jensen M, Kristensen M, Astrup A. 2012. Effect of alginate supplementation on weight loss in obese subjects completing a 12-wk energy-restricted diet: a randomized controlled trial. Am J Clin Nutr 96:5-13.
14. Herder C, Peltonen M, Koenig W, Sütfels K, Lindströ m J, Martin S, Ilanne-Parikka P, et al. 2009. Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia 52: 433-442.
15. Higgins J, Green S. 2011. Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration. Available at: http://www.cochrane-handbook.org. Accessed on 25 May 2012.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. Br Med J 327:557-560.
17. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, McQuay HJ. 1996. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12.
18. Jenkins DJ, Kendall CW, Augustin LS, Martini MC, Axelsen M, Faulkner D, Vidgen E, et al. 2002. Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetes. Diabetes Care 25:1522-1528.
19. Johansson-Persson A, Ulmius M, Cloetens L, Karhu T, Herzig KH, Onning G. 2014. A high intake of dietary fiber influences C-reactive protein and fibrinogen, but not glucose and lipid metabolism, in mildly hypercholesterolemic subjects. Eur J Nutr 53:39-48.
20. Kantor ED, Lampe JW, Kratz M, White E. 2013. Lifestyle factors and inflammation: associations by body mass index. PLoS One 8: e67833.
21. Katcher HI, Legro RS, Kunselman AR, Gillies PJ, Demers LM, Bagshaw DM, Kris-Etherton PM. 2008. The effects of a whole grainenriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am J Clin Nutr 87:79-90.
22. King DE, Egan BM, Woolson RF, Mainous III AG, Al-Solaiman Y, Jesri A. 2007. Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med 167:502-506.
23. King DE, Mainous III AG, Egan BM, Woolson RF, Geesey ME. 2008. Effect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM). Ann Fam Med 6: 100-106.
24. King DE, Mainous III AG, Lambourne CA. 2012. Trends in dietary fiber intake in the United States, 1999-2008. J Acad Nutr Diet 112: 642-648.
25. Kohl A, Gö gebakan O, Mö hlig M, Osterhoff M, Isken F, Pfeiffer AF, Weickert MO. 2009. Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1,3)(1,6)-beta-glycan consumption in overweight humans. Nutr Res 29:248-254.
26. Kristensen M, Toubro S, Jensen MG, Ross AB, Riboldi G, Petronio M, Bügel S, et al. 2012. Whole grain compared with refined wheat decreases the percentage of body fat following a 12-week, energyrestricted dietary intervention in postmenopausal women. J Nutr 142: 710-716.
27. Li JJ, Fang CH. 2004. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypo 62:499-506.
28. Moher D, Liberati A, Tetzlaff J, Altman DG. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br Med J 339:b2535.
29. Ning H, Van Horn L, Shay CM, Lloyd-Jones DM. 2014. Associations of dietary fiber intake with long-term predicted cardiovascular disease risk and C-reactive protein levels (from the National Health and Nutrition Examination Survey Data [2005-2010]). Am J Cardiol 113: 287-291.
30. Qi L, van Dam RM, Liu S, Franz M, Mantzoros C, Hu FB. 2006. Wholegrain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care 29:207-211.
31. Rhee Y, Brunt A. 2011. Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: a randomized crossover design. Nutr J 10:44.
32. Ridker PM. 2003. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107:363-369.
33. Taube A, Schlich R, Sell H, Eckardt K, Eckel J. 2012. Inflammation and metabolic dysfunction: links to cardiovascular diseases. Am J Physiol Heart Circ Physiol 302:H2148-H2165.
34. U.S. Department of Agriculture & U.S. Department of Health and Human Services. 2010. Dietary Guidelines for Americans. Available at: http://www.cnpp.usda.gov/dietaryguidelines.htm. Accessed on 25 December 2012.
35. Wood RJ, Volek JS, Davis SR, Dell'Ova C, Fernandez ML. 2006. Effects of a carbohydrate- restricted diet on emerging plasma markers for cardiovascular disease. Nutr Metab (Lond) 3:19.
36. World Health Organization. (2013). Global Health Observatory (GHO): obesity. Available at: http://www.who.int/gho/ncd/risk-factors/obesity-text/en. Accessed on 01 May 2012.